In the SURPASS 2 trial, Tirzepatide, at all doses (5mg, 10mg and 15mg) was more effective at lowering Hba1c and blood glucose levels compared to Semaglutide 1mg, aka Ozempic
The study, which was published in American Journal of Ophthalmology , analyzed data over about a three-year period from 71 US healthcare organizations of 41,850 patients who initiated tirzepatide and 147,828 patients who initiated selective GLP-1 drugs
Learn more about Auro Wellness products by visiting aurowellness.com
Cada artculo es revisado por profesionales de la salud, garantizando informacin rigurosa y actualizada
T.JanmohamedA.SmithR
8 Its for people who have already reached and tolerated 2.4 mg, and its currently available privately rather than on the NHS